Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)
Not Applicable
Withdrawn
- Conditions
- Hepatocellular CarcinomaMetastatic Liver Cancer
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Techsomed Medical Technologies LTD
- Registration Number
- NCT05641922
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures
Not Applicable
Not yet recruiting
- Conditions
- Metastatic Liver CancerHepatocellular Carcinoma
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Techsomed Medical Technologies LTD
- Target Recruit Count
- 40
- Registration Number
- NCT05582018
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
Completed
- Conditions
- Carcinoma, HepatocellularMetastatic Liver Cancer
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Techsomed Medical Technologies LTD
- Target Recruit Count
- 65
- Registration Number
- NCT04970212
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Stanford Medicine, Stanford, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
News
No news found